[Form 4] Lightbridge Corp. Insider Trading Activity

Rhea-AI Filing Summary

Lightbridge Corp. insider filing: Chief Financial Officer Larry Goldman received multiple equity grants on 08/28/2025 including restricted stock awards and performance-based restricted stock awards plus existing employee stock options. The filing shows five non-derivative award entries totaling incremental grants that increase Mr. Goldman’s beneficial ownership from 211,229 shares up to 337,086 shares as awards vest or are recognized. The restricted stock awards vest over three years in equal annual installments; the performance awards vest only if specified performance goals are met before the end of the performance period on 12/31/2028. Two employee stock options remain reported: a fully vested option with $18.48 strike covering 4,469 shares and an option with $55.20 strike covering 5,449 shares.

Positive

• Grants align executive pay with retention: RSAs vest in three equal annual installments, encouraging continued service
• Performance-based awards included: PSAs link a portion of compensation to achievement of specified performance conditions through 12/31/2028
• Clear disclosure and timing: Transactions dated 08/28/2025 and Form 4 signed 08/29/2025 show timely reporting

Negative

• Potential dilution: Multiple equity grants increase total beneficial ownership and may dilute existing shareholders as awards vest
• Performance awards may forfeit: PSAs will be cancelled if unvested by 12/31/2028, creating uncertainty about ultimate share issuance

Insights

Corporate Compensation Analyst

TL;DR: CFO received time‑based and performance equity grants to retain and incentivize through 2028, with some dilution and long vesting horizons.

These awards are standard executive compensation: time‑vested RSAs promote retention while PSAs tie pay to long‑term performance through 12/31/2028. The incremental increase in reported beneficial ownership to 337,086 shares reflects recognition of granted awards rather than open‑market purchases. The fully vested low‑strike option ($18.48) and higher strike option ($55.20) indicate a mix of near‑term exercisable upside and longer‑dated incentive. For investors, key considerations are potential dilution and whether performance metrics for PSAs are meaningful.

Securities Counsel / Compliance Specialist

TL;DR: Form 4 properly discloses grant details, vesting conditions, and beneficial ownership increases consistent with Section 16 reporting.

The filing includes explicit explanations: RSAs vest in three equal annual installments; PSAs vest subject to certification and lapse if unvested by 12/31/2028. Transaction codes and amounts are provided and the report is signed by the reporting person. From a compliance perspective, disclosure appears complete and timely for a single reporting person filing on 08/29/2025 for transactions dated 08/28/2025.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GOLDMAN LARRY

(Last) (First) (Middle)

C/O LIGHTBRIDGE CORPORATION

11710 PLAZA AMERICA DRIVE, SUITE 2000

(Street)

RESTON VA 20190

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LIGHTBRIDGE Corp [ LTBR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

3. Date of Earliest Transaction (Month/Day/Year)
08/28/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/28/2025		A(1)		41,952	A	$0	211,229	D
Common Stock	08/28/2025		A(2)		41,952	A	$0	253,181	D
Common Stock	08/28/2025		A(2)		41,952	A	$0	295,133	D
Common Stock	08/28/2025		A(2)		25,171	A	$0	320,304	D
Common Stock	08/28/2025		A(2)		16,782	A	$0	337,086	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$18.48							(3)	11/09/2026	Common Stock	4,469		4,469	D
Employee Stock Option (right to buy)	$55.2							(3)	11/20/2025	Common Stock	5,449		5,449	D

Explanation of Responses:

1. Represents a grant of restricted stock awards (RSAs). These RSAs vest in three equal installments on the first, second and third anniversaries of the date of grant, contingent on the reporting person's continued service on each such vesting date.

2. Represents a grant of performance-based restricted stock awards (PSAs). These PSAs vest subject to achievement of a specified performance condition, and at the time of certification thereof, contingent on the reporting person's continued service on the certification date. PSAs that remain unvested as of December 31, 2028 (the end of the performance period) will automatically be forfeited and cancelled without consideration.

3. This option is fully vested as of the date of this report.

	/s/ Larry Goldman	08/29/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did LTBR CFO Larry Goldman receive on 08/28/2025?

The filing reports restricted stock awards (RSAs) and performance-based restricted stock awards (PSAs) granted on 08/28/2025, plus two employee stock options.

How did Larry Goldman’s beneficial ownership change after the reported transactions?

Reported beneficial ownership increases stepwise from 211,229 shares to 337,086 shares as awards are recognized in the filing.

What are the vesting and performance deadlines for the awards?

RSAs vest in three equal annual installments commencing after grant; PSAs vest only upon certification of performance and will be forfeited if unvested by 12/31/2028.

What options does the filing disclose for the reporting person?

Two employee stock options are listed: one fully vested with a $18.48 exercise price for 4,469 shares and another with a $55.20 exercise price for 5,449 shares.

Was the Form 4 filed timely?

The transactions are dated 08/28/2025 and the Form 4 is signed 08/29/2025, indicating prompt filing the next day.